Open AccessFactors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study
Author(s) -
Vasiliki Georgakopoulou,
Dimitrios Basoulis,
Pantazis Voutsinas,
Sotiria Makrodimitri,
Stamatia Samara,
Maria Triantafyllou,
Irene Eliadi,
Georgios Karamanakos,
C. Papageorgiou,
Amalia Anastasopoulou,
Aikaterini Bitsani,
Olga Kampouropoulou,
Ioanna Eleftheriadou,
Aikaterini Gkoufa,
Demetrios A. Spandidos,
Petros Papalexis,
Nikolaos V. Sipsas
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11660
Subject(s) - tocilizumab , medicine , comorbidity , retrospective cohort study , pneumonia , vaccination , mortality rate , immunology , disease